The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
企業コードTOI
会社名Oncology Institute Inc
上場日Mar 13, 2020
最高経営責任者「CEO」Dr. Daniel Virnich, M.D.
従業員数825
証券種類Ordinary Share
決算期末Mar 13
本社所在地18000 Studebaker Rd
都市CERRITOS
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号90703
電話番号15627353226
ウェブサイトhttps://theoncologyinstitute.com/
企業コードTOI
上場日Mar 13, 2020
最高経営責任者「CEO」Dr. Daniel Virnich, M.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし